celecoxib has been researched along with Hyperemia in 3 studies
Hyperemia: The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Whether the chronic administration of HMG-CoA reductase inhibitors provides similar protection remains controversial and is unknown in humans." | 2.77 | Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study. ( Gori, T; Liuni, A; Luca, MC; Parker, JD, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luca, MC | 2 |
| Liuni, A | 2 |
| McLaughlin, K | 1 |
| Gori, T | 2 |
| Parker, JD | 2 |
| Konger, RL | 1 |
| Xu, Z | 1 |
| Sahu, RP | 1 |
| Rashid, BM | 1 |
| Mehta, SR | 1 |
| Mohamed, DR | 1 |
| DaSilva-Arnold, SC | 1 |
| Bradish, JR | 1 |
| Warren, SJ | 1 |
| Kim, YL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Remote Ischaemic Conditioning on Blood Pressure Control in Patients With Chronic Kidney Disease - the ERIC-BP-CKD Trial[NCT03236350] | 85 participants (Anticipated) | Interventional | 2017-11-28 | Recruiting | |||
| A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)[NCT02506062] | 21 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for celecoxib and Hyperemia
| Article | Year |
|---|---|
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Celecoxib; Cyclooxygenase 2 Inhibitors | 2012 |
1 other study available for celecoxib and Hyperemia
| Article | Year |
|---|---|
Spatiotemporal assessments of dermal hyperemia enable accurate prediction of experimental cutaneous carcinogenesis as well as chemopreventive activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Carcinogens; Celecoxib; Cell Tr | 2013 |